Skip to main content
. 2015 Mar 23;10(3):e0121556. doi: 10.1371/journal.pone.0121556

Table 1. Mouse models used in this study.

Mouse model Transgene/Mutation Promoter/Expression Phenotype/Symptoms Original references
DM500 human DM1 locus with ~500 CTG triplets human DMPK promoter/all DM1 related tissues (e.g., skeletal muscle, heart, CNS) homozygous mice: myopathy, reduced muscle strength, myotonia (generally very mild phenotype) [28,29]
DMSXL human DM1 locus with ~1600 CTG triplets human DMPK promoter/all DM1 related tissues (e.g., skeletal muscle, heart, CNS) homozygous mice: myopathy, reduced muscle strength, myotonia, reduced body size (more severe phenotype than DM500 mice) [30]
HSA LR human α-actin gene with ~250 CTG triplets human α-actin promoter/ skeletal muscle only homozygous mice: strong myotonia, myopathy, no muscle weakness [27]
mdx spontaneous point mutation in dystrophin gene ubiquitous (e.g., skeletal muscle, heart, CNS, retina) hemizygous mice: muscle degeneration and atrophy, skeletal muscle fibrosis and necrosis [32,33]
WT no transgene (genetic background >90% C57BL/6) n.a. n.a. n.a.